Spexin as an anxiety regulator in mouse hippocampus: Mechanisms for transcriptional regulation of spexin gene expression by corticotropin releasing factor.
Spexin as an anxiety regulator in mouse hippocampus: Mechanisms for transcriptional regulation of spexin gene expression by corticotropin releasing factor.
复制标题
Spexin 作为小鼠海马的焦虑调节剂:促肾上腺皮质激素释放因子转录调节 Spexin 基因表达的机制。
DOI:
10.1016/j.bbrc.2020.02.023
复制
发表时间:
2020-02
期刊:
影响因子:
--
通讯作者:
Zeng Guangzhi
中科院分区:
文献类型:
--
作者:
Zhuang Min;Lai Qi;Yang Chunju;Ma Yanhua;Fan Baomin;Bian Zhaoxiang;Lin Chengyuan;Bai Jin;Zeng Guangzhi
Spexin (SPX) acts as a neuropeptide with pleiotropic functions that can participate in anxiety regulation. Corticotropin releasing factor (CRF) is widely expressed in brain tissues and associated with depression and anxiety and addiction. With the anxious mice under chronic unpredictable stress, we found SPX mRNA expression level in the hippocampus of the brain was significantly reduced, while local CRF mRNA expression level was increased. Furthermore, CRF injection in the hippocampus could also decrease SPX mRNA expression levels in hippocampus and other brain tissues, including pituitary and hypothalamus. With the primary mouse hippocampal cell model, CRF treatment could decrease SPX mRNA expression at hippocampal cell level and this inhibitory effect was mediated only by corticotropin releasing factor receptor 2 (CRFR2) but not corticotropin releasing factor receptor 1 (CRFR1). In HEK293 cells with CRFR2 over-expression, CRF could also inhibit SPX promoter activity coupling with AC/cAMP/PKA and MEK1/2/Erk1/2cascades. In addition, Epac was also involved with the CRF-repressed SPX promoter activity and cross-talked with MEK1/2/Erk1/2pathway. CRF could inhibit SPX gene expression in mouse hippocampus via transcriptional activation at the promoter level with coupling of AC/cAMP and MEK1/2/Erk1/2signaling, which will be relevant to the anxiety response mediated by SPX in central nervous system.
登录
查看更多内容
影响因子:
56.9
作者:
Kawasaki, H;Springett, GM;Graybiel, AM
通讯作者:
Graybiel, AM
影响因子:
4
作者:
Lin CY;Zhao L;Huang T;Lu L;Khan M;Liu J;Zhong LLD;Cai ZW;Fan BM;Wong AOL;Bian ZX
通讯作者:
Bian ZX
影响因子:
3.3
作者:
Hatalski, CG;Brunson, KL;Baram, TZ
通讯作者:
Baram, TZ
影响因子:
14.8
作者:
Beaudoin, Gerard M. J., III;Lee, Seung-Hye;Arikkath, Jyothi
通讯作者:
Arikkath, Jyothi
DOI:
10.1016/j.ejphar.2019.03.037
发表时间:
2019
期刊:
Eur J Pharmacol.
影响因子:
--
作者:
Nozu T;Miyagishi S;Nozu R;Takakusaki K;Okumura T.
通讯作者:
Okumura T.